Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06827262

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Conditions: Chronic Low-back Pain, Vertebrogenic Pain Syndrome

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 1500

Sponsor: Boston Scientific Corporation

Location: Flagstaff Bone & Joint Flagstaff Arizona

Summary

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Eligibility Criteria

Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU). * Signed a valid, IRB/EC-approved informed consent form. Exclusion Criteria: * Meets any contraindications per locally applicable Instructions for Use (IFU).

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06827262). StuddyBuddy aggregates publicly available trial information.